ANDA 80390, held by Lyphomed. Lidocaine Hydrochloride.
As of Nov 16, 2026, ANDA 80390 (Lidocaine Hydrochloride), held by Lyphomed, was first approved by FDA on Mar 14, 1977, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 14, 1977 | Original application | Approved | None posted |
| Lidocaine Hydrochloride1% · injectable;injection | Lidocaine Hydrochloride | Discontinued |
| Lidocaine Hydrochloride2% · injectable;injection | Lidocaine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters